BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 37070986)

  • 1. Imprinted Anti-Hemagglutinin and Anti-Neuraminidase Antibody Responses after Childhood Infections of A(H1N1) and A(H1N1)pdm09 Influenza Viruses.
    Daulagala P; Mann BR; Leung K; Lau EHY; Yung L; Lei R; Nizami SIN; Wu JT; Chiu SS; Daniels RS; Wu NC; Wentworth D; Peiris M; Yen HL
    mBio; 2023 Jun; 14(3):e0008423. PubMed ID: 37070986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic Drift of the Influenza A(H1N1)pdm09 Virus Neuraminidase Results in Reduced Effectiveness of A/California/7/2009 (H1N1pdm09)-Specific Antibodies.
    Gao J; Couzens L; Burke DF; Wan H; Wilson P; Memoli MJ; Xu X; Harvey R; Wrammert J; Ahmed R; Taubenberger JK; Smith DJ; Fouchier RAM; Eichelberger MC
    mBio; 2019 Apr; 10(2):. PubMed ID: 30967460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
    Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
    BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
    Walz L; Kays SK; Zimmer G; von Messling V
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of amino acid substitutions supporting antigenic change of influenza A(H1N1)pdm09 viruses.
    Koel BF; Mögling R; Chutinimitkul S; Fraaij PL; Burke DF; van der Vliet S; de Wit E; Bestebroer TM; Rimmelzwaan GF; Osterhaus AD; Smith DJ; Fouchier RA; de Graaf M
    J Virol; 2015 Apr; 89(7):3763-75. PubMed ID: 25609810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
    Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of A(H1N1)pdm09 vaccine seed viruses: The source of PB1 and HA vRNA as a major determinant for antigen yield.
    Almeida F; Santos LA; Trigueiro-Louro JM; Rebelo-de-Andrade H
    Virus Res; 2022 Jul; 315():198795. PubMed ID: 35504447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Universal Influenza Virus Neuraminidase Vaccine Elicits Protective Immune Responses against Human Seasonal and Pre-pandemic Strains.
    Skarlupka AL; Bebin-Blackwell AG; Sumner SF; Ross TM
    J Virol; 2021 Aug; 95(17):e0075921. PubMed ID: 34160258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenicity of the 2015-2016 seasonal H1N1 human influenza virus HA and NA proteins.
    Clark AM; DeDiego ML; Anderson CS; Wang J; Yang H; Nogales A; Martinez-Sobrido L; Zand MS; Sangster MY; Topham DJ
    PLoS One; 2017; 12(11):e0188267. PubMed ID: 29145498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Synthetic Dual Agonistic Liposomal TLR4/7 Adjuvant Promotes Broad Immune Responses in an Influenza Vaccine With Minimal Reactogenicity.
    Sato-Kaneko F; Yao S; Lao FS; Shpigelman J; Messer K; Pu M; Shukla NM; Cottam HB; Chan M; Chu PJ; Burkhart D; Schoener R; Matsutani T; Carson DA; Corr M; Hayashi T
    Front Immunol; 2020; 11():1207. PubMed ID: 32636840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly Cross-Reactive and Protective Influenza A Virus H3N2 Hemagglutinin- and Neuraminidase-Specific Human Monoclonal Antibodies.
    Piepenbrink M; Oladunni F; Nogales A; Khalil AM; Fitzgerald T; Basu M; Fucile C; Topham DJ; Rosenberg AF; Martinez-Sobrido L; Kobie JJ
    Microbiol Spectr; 2023 Aug; 11(4):e0472822. PubMed ID: 37318331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic and genetic characterization of influenza viruses circulating in Bulgaria during the 2015/2016 season.
    Korsun N; Angelova S; Gregory V; Daniels R; Georgieva I; McCauley J
    Infect Genet Evol; 2017 Apr; 49():241-250. PubMed ID: 28132927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune Escape Adaptive Mutations in Hemagglutinin Are Responsible for the Antigenic Drift of Eurasian Avian-Like H1N1 Swine Influenza Viruses.
    Xu C; Zhang N; Yang Y; Liang W; Zhang Y; Wang J; Suzuki Y; Wu Y; Chen Y; Yang H; Qiao C; Chen H
    J Virol; 2022 Aug; 96(16):e0097122. PubMed ID: 35916512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Directed selection of amino acid changes in the influenza hemagglutinin and neuraminidase affecting protein antigenicity.
    DeDiego ML; Chiem K; Topham DJ
    Vaccine; 2018 Oct; 36(43):6383-6392. PubMed ID: 30224200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extending the Stalk Enhances Immunogenicity of the Influenza Virus Neuraminidase.
    Broecker F; Zheng A; Suntronwong N; Sun W; Bailey MJ; Krammer F; Palese P
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31375573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-neuraminidase antibodies against pandemic A/H1N1 influenza viruses in healthy and influenza-infected individuals.
    Desheva Y; Sychev I; Smolonogina T; Rekstin A; Ilyushina N; Lugovtsev V; Samsonova A; Go A; Lerner A
    PLoS One; 2018; 13(5):e0196771. PubMed ID: 29742168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-Linked Glycans and K147 Residue on Hemagglutinin Synergize To Elicit Broadly Reactive H1N1 Influenza Virus Antibodies.
    Huang Y; Owino SO; Crevar CJ; Carter DM; Ross TM
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31852790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic drift of hemagglutinin and neuraminidase in seasonal H1N1 influenza viruses from Saudi Arabia in 2014 to 2015.
    Naeem A; Elbakkouri K; Alfaiz A; Hamed ME; Alsaran H; AlOtaiby S; Enani M; Alosaimi B
    J Med Virol; 2020 Dec; 92(12):3016-3027. PubMed ID: 32159230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses.
    Sandbulte MR; Westgeest KB; Gao J; Xu X; Klimov AI; Russell CA; Burke DF; Smith DJ; Fouchier RA; Eichelberger MC
    Proc Natl Acad Sci U S A; 2011 Dec; 108(51):20748-53. PubMed ID: 22143798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.